Ilya Yuffa is executive vice president of Eli Lilly and Company and president of Lilly International.
With a tenure of more than 25 years at Lilly, Ilya most recently served as senior vice president of Lilly Bio-Medicines and previously vice president of U.S. Diabetes for Lilly USA from 2018 to 2020.
Since joining Lilly in 1996 as a financial analyst, Ilya has held a number of positions in finance, business development, sales and general management. He served as managing director of the Israeli affiliate from 2008 until 2011, senior sales director of osteoporosis from 2011 until 2013, and held senior leadership positions within six sigma and ethics and compliance from 2013 until 2017. In 2017, Ilya was named president and general manager of Lilly’s Italy Hub, leading the commercialization of the entire Lilly portfolio in more than 25 countries.
Born in St. Petersburg, Russia, Ilya grew up in Colorado. His career has taken him around the world, and he has lived and worked in the United Kingdom, Czech Republic, Italy and Israel.
Ilya earned a Bachelor of Science degree from Tulane University in 1996, and a Master of Business Administration degree from the London Business School in 2002.
Ilya is a member of the Board of Directors for the U.S.-Japan Business Council and the Advisory Board of the U.S. Chamber of Commerce China Center. He also serves as a board member for the European Federation of Pharmaceutical Industries and the management committee of Business Equity for Indy.
